This HTRF kit enables the cell-based quantitative detection of Total XBP1 (XBP1u + XBP1s) as a readout of ER stress. This kit can be used as a normalization assay with our XBP1s kit to enable optimal investigation of the IRE1a/XBP1 pathway.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 16 µL |
This HTRF kit enables the cell-based quantitative detection of Total XBP1 (XBP1u + XBP1s) as a readout of ER stress. This kit can be used as a normalization assay with our XBP1s kit to enable optimal investigation of the IRE1a/XBP1 pathway.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
The HTRF Human XBP1 detection assay monitors spliced XBP1 (XBP1s) as well as unspliced XBP1 (XBP1u), and is used to detect the expression of endogenous or overexpressed global XBP1 (XBP1s + XBP1u) in various cells.
Upon ER stress and accumulation of unfolded proteins, BiP releases its inhibitory binding to activate IRE1. IRE1 receptor dimerizes then autophosphorylates which activates its mRNase activity. Through this action, IRE1 splices XBP-1u mRNA to XBP1s, enabling its translation and then its translocation to the nucleus. XBP-1s then acts as a transcription factor.
Application |
Cell Signaling
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Lysis Buffer Compatibility |
Lysis Buffer 1
Lysis Buffer 2
Lysis Buffer 4
|
Molecular Modification |
Total
|
Product Group |
Kit
|
Sample Volume |
16 µL
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Phosphoproteins
|
Target Species |
Human
|
Technology |
TR-FRET
|
Unit Size |
500 Assay Points
|
The HTRF Human Total XBP1 assay quantifies the expression level of XBP1 (XBP1u + XBP1s) in a cell lysate. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer. The Human Total XBP1 assay uses two labeled antibodies, one coupled to a donor fluorophore and the other to an acceptor. Both antibodies are highly specific for a distinct epitope on the protein. In presence of XBP1s or XBP1u in a cell extract, the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor, and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the protein present in the sample, and provides a means of assessing the protein’s expression under a no-wash assay format.
The two-plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates into a 384-well low volume detection plate before the addition of Human Total XBP1 HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.
Detection of Human Total XBP1 with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.
Hep-G2 or MCF7 cells were plated at 100,000 cells per well in a 96-well culture-treated plate in complete culture medium, and incubated overnight at 37°C, 5% CO2. They were treated with increasing concentrations of Thapsigargin for 4h at 37 °C, 5% CO2, and then lysed with 50 µl of supplemented lysis buffer #1 (1X) for 30 min at RT under gentle shaking.
After cell lysis, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF Total-XBP1 and XBP1s detection reagents were added. The HTRF signal was recorded after 18h of incubation at room temperature.
As expected, Thapsigargin compound induced the translation of the XBP1s form, with a dose-dependent increase in the XBP1s signal level. The Total XBP1 signal slightly increased as well with this treatment.
MCF7 cells were plated at 100,000 cells per well in a 96-well culture-treated plate in complete culture medium, and incubated overnight at 37°C, 5% CO2. They were co-treated with Thapsigargin (EC80: 150 nM) and increasing concentrations of 2 inhibitors (APY29 and MKC3946) for 4h at 37 °C, 5% CO2, then lysed with 50 µl of supplemented lysis buffer #1 (1X) for 30 min at RT under gentle shaking.
After cell lysis, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF Total XBP1 detection reagents were added. The HTRF signal was recorded after 18h of incubation at room temperature.
As expected, the slight HTRF signal induced by Thapsigargin stimulation was inhibited by both the APY29 and MKC3946 compounds with IC50 at 1.1 and 1.7 µM respectively, meaning that less Total XBP1 had been expressed.
HAP1 and HAP1 XBP1 KO cells (from Horizon Discovery) were cultured in a T175 flask in a complete culture medium for 24h at 37°C, 5% CO2. The cells were lysed with 3 mL of supplemented lysis buffer # 1 for 30 minutes at RT under gentle shaking, and 16 µL of lysate were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF Total XBP1 detection reagents. The HTRF signal was recorded after an overnight incubation.
No signal was detected on the HAP1 XBP1 KO cells whereas a signal was detected on the HAP1 wt, proving the specificity of the assay for XBP1 protein.
Adherent human & mouse HAP1, MCF7, and Hep-G2 cells were seeded at 100,000 cells / well in a 96-well microplate. After a 24h incubation, the cells were treated with Thapsigargin for 4h at 37°C. The cells were then lysed with supplemented lysis buffer #1, and 16 µL of lysate were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF total XBP1 detection reagents. The HTRF signal was recorded after an overnight incubation.
The HTRF total XBP1 assay efficiently detected XBP1 proteins (XBP1s + XBP1s) in various cellular models expressing different levels of the protein.
MCF7 cells were cultured in a T175 flask in a complete culture medium for 24h at 37°C, 5% CO2. After treatment with 700 nM of Thapsigargin compound for 4h at 37°C, 5% CO2, the cells were then lysed with 3 mL of supplemented lysis buffer #1 (1x) for 30 minutes at RT under gentle shaking.
Serial dilutions of the cell lysate were performed using supplemented lysis buffer #1 (1x), and 16 µL of each dilution were transferred into a low volume white microplate before the addition of 4 µL of HTRF Total XBP1 detection reagents.
Equal amounts of lysates were used for a side-by-side comparison between HTRF and Western Blot.
In these conditions, the HTRF Total XBP1 assay was 2 times more sensitive than the Western Blot technique.
XBP1 is a key component of the Unfolded protein response (UPR) that modulates cellular survival. There are three UPR pathways involving different mediators such as ATF6, IRE1 and PERK, and leading to significant downstream effects.
Upon ER stress, and the accumulation of unfolded proteins, BiP releases its inhibitory binding of the three ER stress proteins and activates them.
When activated, IRE1 first dimerizes, then autophosphorylates which activates its mRNase activity. Through this action, IRE1 splices XBP-1u mRNA to XBP1s, enabling its translation and then its translocation to the nucleus. XBP-1s then acts as a transcription factor.
Are you looking for resources, click on the resource type to explore further.
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
This guide provides you an overview of HTRF applications in several therapeutic areas.
We are here to answer your questions.